코로나19 백신 개발사 큐어백 “임상시험서 면역반응” German biotech company, CureVac, recorded an immune reaction from a potential vaccine in a clinical trial on Monday. According to local media outlets, its CEO Franz-Werner Haas was encouraged by the interim results from…

[김지연 기자 아이템] 집단 면역 논란 There’s controversy over whether herd immunity can be a solution to solving the COVID-19 outbreak. We sit down with our in-house reporter to discuss this issue. 코로나19 사태 이후 집단 면역이 하나의 대응이 될…

미 CDC “코로나19, 제한적 이례적 상황서 공기 감염 가능”, 노스웨스턴 “코로나19 입원 환자 3분의 1은 뇌질환” Health authorities in the U.S. have officially acknowledged that COVID-19 can be transmitted through particles in the air, not just water droplets. These particles,…

‘코로나 입원’ 트럼프, 개발 중 항체약물과 렘데시비르, 스테로이드 등 투약 74 years old, male and overweight. President Trump has all these factors linked to more severe cases of COVID-19. To help relieve symptoms and shorten hospital stay, his physicians are…

코로나19 백신 “모든 투약자 면역 반응 생성”…글로벌 혈장치료 임상도 40배 늘어 Some promising signs of vaccines and treatments for COVID-19 are emerging. Scientists at Oxford University in the U.K. say their experimental vaccine has led to an immune response in…

영국 옥스퍼드대 코로나19 백신 “모든 투약자 면역 반응 생성” We begin with some potentially positive news. As the world awaits an effective vaccine against COVID-19,… some promising signs are emerging. Scientists at Oxford University in the U.K. say their experimental…